Profit

BSE Code: | NSE Code: | ISIN: | Sector:

NSE
750.15
Change Change %
-3.35 -0.44%

Updated:16 Nov, 2018, 14:24 PM IST

BSE
751.50
Change Change %
-0.30 -0.04%

Updated:16 Nov, 2018, 14:52 PM IST

Research Report Detail

Brokerage
Analyst
Report Date Call Price@Call Target Price
Stop Loss
Current Status Time Horizon
Nomura
N/A
20-07-2017 Buy 736.05 855.00
N/A
Target Hit Long (1Y)
20-07-2018

Nomura retains buy on Jubilant Lifesciences

1QFY18 results came in slightly lower than our expectations. Revenues were 2% ahead of our forecast, primarily driven by stronger growth in the Life Science Ingredient segment. EBITDA was 5% below our assumption (down 480bps y-y) mainly due to lower gross margin. Net earnings recorded a 2% fall y-y and came in 6% below our estimate.We cut FY18F/19F EPS by13%/6%. Our new, lower TP of INR855 is based on 15x (unchanged) FY19F EPS of INR57.0.

Top